» Articles » PMID: 8699033

Time-resolved Fluorometric Assay for Natural Killer Activity Using Target Cells Labelled with a Fluorescence Enhancing Ligand

Overview
Publisher Elsevier
Date 1996 Jun 21
PMID 8699033
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

A time-resolved fluorometric assay for the measurement of natural killer cell activity against target cells labelled with the acetoxymethyl ester of the fluorescence enhancing ligand 2,2':6',2"-terpyridine-6,6"-dicarboxylic acid (TDA) is described. The hydrophobic esterified form of TDA (bis(acetoxymethyl) 2,2':6',2"-terpyridine-6,6"-dicarboxylate, BATDA) diffuses readily through the cell membrane of viable cells. BATDA is hydrolysed by intracellular esterases resulting in accumulation of membrane impermeable TDA inside the target cells. After incubation of labelled K-562 cells with effector cells the TDA released from lysed cells into the supernatant is chelated with Eu3+. The natural killer cell activity is then quantified by measuring the intense fluorescence of the EuTDA chelates formed. Target cells are rapidly labelled when incubated with BATDA, TDA is released from target cells faster than 51Cr, the spontaneous release permits a short-term release assay to be set up and the detection of EuTDA is fast (5 min/96 well plate). Furthermore, this non-radioactive method permits the use of complex culture media since, in contrast to methods based on prompt fluorometry, the problem with autofluorescence can be avoided by the use of time-resolved fluorometry.

Citing Articles

Distinct CD16a features on human NK cells observed by flow cytometry correlate with increased ADCC.

Benavente M, Hakeem Z, Davis A, Murray N, Azadi P, Mace E Sci Rep. 2024; 14(1):7938.

PMID: 38575779 PMC: 10995120. DOI: 10.1038/s41598-024-58541-6.


Inhibiting N-glycan processing increases the antibody binding affinity and effector function of human natural killer cells.

Rodriguez Benavente M, Hughes H, Kremer P, Subedi G, Barb A Immunology. 2023; 170(2):202-213.

PMID: 37218360 PMC: 10524233. DOI: 10.1111/imm.13662.


Personal Neoantigens From Patients With NSCLC Induce Efficient Antitumor Responses.

Zhang W, Yin Q, Huang H, Lu J, Qin H, Chen S Front Oncol. 2021; 11:628456.

PMID: 33928024 PMC: 8076796. DOI: 10.3389/fonc.2021.628456.


Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions .

Pradier A, Papaserafeim M, Li N, Rietveld A, Kaestel C, Gruaz L Front Immunol. 2019; 10:556.

PMID: 30972058 PMC: 6445861. DOI: 10.3389/fimmu.2019.00556.


Determination of human γδ T cell-mediated cytotoxicity using a non-radioactive assay system.

Tagod M, Mizuta S, Sakai Y, Iwasaki M, Shiraishi K, Senju H J Immunol Methods. 2019; 466:32-40.

PMID: 30654042 PMC: 6817948. DOI: 10.1016/j.jim.2019.01.003.